LENOVO
Lenovo and world football (soccer) association Football Club Internazionale Milano (Inter) have upgraded their multi-year partnership taking the prized back-of-shirt placement on the team’s iconic jersey, starting in the 2021/2022 season. Lenovo has been the official Global Technology Partner since 2019, where it has been instrumental in transforming the club’s digital experience, providing both Inter’s Suning Training Center in Appiano Gentile and their headquarters with vital smarter technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210713005118/en/
From servers, data management, storage and smart collaboration devices, through to laptops, monitors and accessories, as part of the upgraded partnership Lenovo will be supporting Inter with technology to gather and manage large amounts of data, transform operations, and deliver better results on and off the pitch. Lenovo’s smarter tech enables Inter to digitize historical archives and documents for easier data access.
Inter’s heritage is second to none. The only club to participate in the top-flight of Italian football since its inception in 1909, they have been crowned champions of the European cup three times. With 19 Serie A titles to their name, they are the reigning Italian champions.
Lenovo’s partnership has delivered on a number of operational performance improvements for Inter since 2019:
- Inter’s data processing performance and speed has improved by 20 percent, managing over 100 million GPS data points collected over the past two seasons during training, including 60 million player-related data points that must be wrangled
- The computational power of Lenovo’s servers has reduced the time it takes Inter to process reports by 25 percent
- Lenovo data storage is fundamental to supporting 50,000 hours of digital video made available as part of the Media Asset Management (MAM), enabling the hosting of 400 terabytes of digital content on the Inter digital archive
- Provides one of the most advanced performance analysis work-flows in Italy, enabling improved stability, flexibility, scalability and security
Shirt Sponsorship
The upgraded shirt sponsorship deal elevates the union of the two iconic brands and their shared values in high performance and relentless innovation. The Lenovo logo’s strategic placement in the coveted back-of-shirt spot on the team’s jersey will lead to a significant increase in brand visibility, including in both Serie A and Coppa Italia.
Global Technology Partner
The past two years have seen Lenovo become deeply embedded in the club as its Global Technology Partner. This includes integrating edge server devices to allow for even greater efficiencies in the collection and processing of data, as well as Lenovo’s high-performance PCs, monitors and smart collaboration devices. The latest agreement will see Lenovo provide Inter with a complete IT solution across hardware, software and support:
- Player Technology: Unrivalled data storage and processing powers will unleash analytics and player development. Structured and unstructured data points will provide tactical insights into player fitness and match analysis. During training sessions, Global Positioning System (GPS) is also used to analyze player speed, distance, workload and the impact on overall team performance, to inform Inter’s training schedule. The data will be used by the team during training sessions to not only review matches, but strategically plan the next games.
- Fan Technology: Bringing over 50 million fans (with more followers in Asia than any other Italian club), Lenovo technology enhances matchday experiences and provides a window into the day-to-day activities of this legend of football. Lenovo’s Media Asset Management (MAM) solution provides Inter with a huge online historical archive of digital assets, including 50,000 hours of video alone, which is easily accessible and customizable on demand. For example, fans can enter their name and date of birth into the Inter digital archive to find out what has happened at the club during their lifetime.
- Business Technology: Lenovo has matched smart technology to Inter’s present need and is providing expertise for the technological development of the club’s headquarters and training facilities. Ushering in the future of work, Lenovo’s world-leading hardware and software solutions include ThinkPad™ laptops, ThinkVision™ monitors and ThinkSmart™ collaboration devices and more for remote/hybrid collaboration and streamlining business operations. Using Lenovo’s smarter tech has allowed for Inter to collaborate seamlessly through web conferencing and remote working.
FC Internazionale Milano Corporate CEO, Alessandro Antonello, said , “The fusion of football and technology is now essential in driving Inter to new heights – from the way we interact with our fans to the tools we have available – this Lenovo partnership sits at the heart of all of it. We’re pleased to deepen our partnership with Lenovo: together we can fuel innovation to make Inter increasingly technologically advanced and forward-looking.”
“Since first coming together, our technology partnership with FC Internazionale Milano has delivered real tangible improvements in performance. More than a sponsorship, this is a meeting of winning mentalities dedicated to continued success both on and off the pitch,” said Luca Rossi, President of Intelligent Devices Group, Lenovo . “Focused on a bold vision to enable smarter technology for all, we’re eager to continue strengthening our partnership to make real advances in digitally transforming Inter into a club of the future for its next generation of fans and wider community.”
About FC Internazionale Milano
Founded in 1908, FC Internazionale Milano, or Inter, is globally renowned as one of the world's most successful football teams. Chinese group Suning acquired the majority stake of the Club in June 2016. The year 2021 has seen the Club meet two very important milestones: the unveiling of the new Inter Logo, celebrated by the I M narrative, and the victory of the 19th Scudetto, 11 years after the Triplete. The club's trophy haul includes 19 Italian league titles, 7 Coppa Italias, 5 Italian Super Cups, 3 UEFA Cups, 2 European Cups, 1 UEFA Champions League, 2 Intercontinental Cups and 1 FIFA Club World Cup. Inter is one of the seven teams to have done the treble – Champions League, national championship and national cup – in the same year (2010), and the only Italian club never to have been relegated in its 113-year history. Inter is a global brand with more than 400 million followers worldwide. The club boasts a cutting-edge, world-famous youth academy. Over the years Nerazzurri youth teams have won more than 56 trophies, producing many full internationals and dozens of other professionals who have gone on to play in the major European leagues.
About Lenovo
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$60 billion revenue Fortune Global 500 company serving customers in 180 markets around the world. Focused on a bold vision to deliver smarter technology for all, we are developing world-changing technologies that power (through devices and infrastructure) and empower (through solutions and software) millions of customers every day and together create a more inclusive, trustworthy and sustainable digital society for everyone, everywhere. To find out more visit https://www.lenovo.com and read about the latest news via our StoryHub .
LENOVO, THINKPAD, THINKVISION and THINKSMART are trademarks of Lenovo. All other trademarks are the property of their respective owners. ©2021, Lenovo Group Limited.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005118/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma19.10.2025 19:30:00 CEST | Press release
Data presented at ESMO 2025 show INCA33890, a TGFβR2×PD-1 bispecific antibody, has the potential to be an effective treatment in microsatellite stable (MSS) colorectal cancerPlanned initiation of registrational program for INCA33890 in MSS colorectal cancer in 2026Maturing data for INCB161734, a KRAS G12D inhibitor, shows a favorable safety profile and evidence of clinical benefit in heavily pre-treated pancreatic ductal adenocarcinoma (PDAC) patientsIncyte will expand on the results from the oral presentations at an in-person and webcasted event on Sunday, October 19, 2025, from 1:30 – 3:00 p.m. EDT (7:30 – 9:00 p.m. CEST) Incyte (Nasdaq:INCY) announced the first clinical data evaluating its TGFβR2×PD-1 bispecific antibody (INCA33890) for patients with microsatellite stable (MSS) colorectal cancer; and its potent, selective and orally bioavailable KRAS G12D inhibitor (INCB161734) for patients with KRAS G12D mutations, specifically pancreatic ductal adenocarcinoma (PDAC). The data were
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment19.10.2025 11:15:00 CEST | Press release
New data from pivotal Phase 3 ROSELLA trial reinforce relacorilant plus nab-paclitaxel improves progression-free and overall survival in patients with platinum-resistant ovarian cancer, with no need for biomarker selection – including in people who progressed while on or after taking a PARP inhibitor, a patient population with particularly poor prognosis Corcept expands BELLA trial to three study arms: (i) platinum-resistant ovarian cancer, (ii) platinum-sensitive ovarian cancer and (iii) endometrial cancer Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today shared new late-breaking data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the European Society for Medical Oncology (ESMO) 2025 Annual
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release
– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom